{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T16:23:34Z","timestamp":1778171014159,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100015757","name":"Regional Government of Andalucia Department of Health and Families Progress and Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015757","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011011","name":"Government of Andalusia","doi-asserted-by":"publisher","award":["PIN-0180-2018"],"award-info":[{"award-number":["PIN-0180-2018"]}],"id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jacl.2025.12.022","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:23:12Z","timestamp":1767658992000},"page":"629-638","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Heterogeneous nature of severe hypertriglyceridemia in childhood"],"prefix":"10.1016","volume":"20","author":[{"given":"Mar\u00eda\u00a0Jos\u00e9","family":"Ariza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Rioja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ver\u00f3nica\u00a0Adriana","family":"Seidel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar","family":"Tol\u00edn-Hernani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurora","family":"Gonz\u00e1lez-Estrada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9\u00a0Carlos","family":"Salazar-Quero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ovidio","family":"Mu\u00f1iz-Grijalvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alipio","family":"Mangas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda\u00a0Rosario","family":"Benavides-Rom\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0940-5963","authenticated-orcid":false,"given":"Marina","family":"Mora-Sitja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Blasco-Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6789-1563","authenticated-orcid":false,"given":"Raquel","family":"Yahyaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"de las Heras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8176-6750","authenticated-orcid":false,"given":"Mar\u00eda","family":"Unceta-Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel\u00a0Francisco","family":"Jim\u00e9nez-Navarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa\u00a0Mar\u00eda","family":"Ord\u00f3\u00f1ez-Sim\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Esp\u00edldora-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Ben\u00edtez-Toledo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inmaculada","family":"Coca-Prieto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel\u00a0\u00c1ngel","family":"S\u00e1nchez-Chaparro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"47","key":"10.1016\/j.jacl.2025.12.022_bib1","first-page":"4791","article-title":"Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies\u2014a consensus statement from the European Atherosclerosis Society","volume":"42","author":"Ginsberg","year":"2021","journal-title":"Eur\u00a0Heart J"},{"issue":"2","key":"10.1016\/j.jacl.2025.12.022_bib2","first-page":"305","article-title":"The prevalence and etiology of extreme hypertriglyceridemia in children: data from a tertiary children\u2019s hospital","volume":"12","author":"Patni","year":"2018","journal-title":"J\u00a0Clin\u00a0Lipidol"},{"key":"10.1016\/j.jacl.2025.12.022_bib3","article-title":"Hypertriglyceridemia-induced acute pancreatitis in children: a mini-review","volume":"10","author":"Grisham","year":"2022","journal-title":"Front\u00a0Pediatr"},{"key":"10.1016\/j.jacl.2025.12.022_bib4","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jpeds.2021.12.017","article-title":"Hypertriglyceridemia in youth","volume":"243","author":"Wilson","year":"2022","journal-title":"J\u00a0Pediatr"},{"issue":"101365","key":"10.1016\/j.jacl.2025.12.022_bib5","first-page":"1","article-title":"Pathogenicity assessment of genetic variants identified in patients with severe hypertriglyceridemia: novel cases of familial chylomicronemia syndrome from the Dyslipidemia Registry of the Spanish Atherosclerosis Society","volume":"27","author":"Ariza","year":"2025","journal-title":"Genet\u00a0Med"},{"issue":"3","key":"10.1016\/j.jacl.2025.12.022_bib6","first-page":"382","article-title":"Familial chylomicronemia syndrome: an expert clinical review from the National Lipid Association","volume":"19","author":"Javed","year":"2025","journal-title":"J\u00a0Clin\u00a0Lipidol"},{"issue":"October 2018","key":"10.1016\/j.jacl.2025.12.022_bib7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.atherosclerosis.2018.12.019","article-title":"Chylomicronemia: differences between familial chylomicronemia syndrome and multifactorial chylomicronemia","volume":"283","author":"Paquette","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2025.12.022_bib8","first-page":"13","article-title":"Quilomicronemia multifactorial: claves para la detecci\u00f3n de las formas severas","volume":"36","author":"Mu\u00f1iz-Grijalvo","year":"2024","journal-title":"Cl\u00edn\u00a0Investig\u00a0Arterioscler"},{"key":"10.1016\/j.jacl.2025.12.022_bib9","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.atherosclerosis.2018.06.814","article-title":"Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): expert panel recommendations and proposal of an \u201cFCS score\u201d","volume":"275","author":"Moulin","year":"2018","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.jacl.2025.12.022_bib10","first-page":"83","article-title":"Development and validation of clinical criteria to identify familial chylomicronemia syndrome (FCS) in North America","volume":"19","author":"Hegele","year":"2025","journal-title":"J\u00a0Clin\u00a0Lipidol"},{"issue":"3","key":"10.1016\/j.jacl.2025.12.022_bib11","first-page":"431","article-title":"Novel PPARG mutation in multiple family members with chylomicronemia","volume":"15","author":"Glodowski","year":"2021","journal-title":"J\u00a0Clin\u00a0Lipidol"},{"issue":"10","key":"10.1016\/j.jacl.2025.12.022_bib12","first-page":"978","article-title":"Very severe hypertriglyceridemia complicating pediatric acute lymphoblastic leukemia treatment: a call for management guidelines","volume":"36","author":"Baxter","year":"2023","journal-title":"J\u00a0Pediatr\u00a0Endocrinol\u00a0Metab"},{"issue":"2","key":"10.1016\/j.jacl.2025.12.022_bib13","article-title":"Drug induced very severe hypertriglyceridemia in a pediatric stem cell transplant recipient","volume":"69","author":"Schweiger","year":"2022","journal-title":"Pediatr\u00a0Blood\u00a0Cancer"},{"issue":"8","key":"10.1016\/j.jacl.2025.12.022_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ph16081069","article-title":"Rapid resolution of life-threatening hypertriglyceridemia after evinacumab administration in a pediatric HSCT recipient: a case report","volume":"16","author":"Fachin","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.jacl.2025.12.022_bib15","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1542\/peds.2011-0217","article-title":"Plasmapheresis to treat hypertriglyceridemia in a child with diabetic ketoacidosis and pancreatitis","volume":"129","author":"Lutfi","year":"2012","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.jacl.2025.12.022_bib16","first-page":"1","article-title":"Role of lipoprotein lipase activity measurement in the diagnosis of familial chylomicronemia syndrome","volume":"17","author":"Rioja","year":"2023","journal-title":"J\u00a0Clin\u00a0Lipidol"},{"issue":"5","key":"10.1016\/j.jacl.2025.12.022_bib17","first-page":"38","article-title":"The CARE guidelines: consensus-based clinical case reporting guideline development","volume":"2","author":"Gagnier","year":"2013","journal-title":"BMJ Case Rep"},{"issue":"12","key":"10.1016\/j.jacl.2025.12.022_bib18","article-title":"Evaluation of the chylomicron-TG to VLDL-TG ratio for type I hyperlipoproteinemia diagnostic","volume":"50","author":"Rioja","year":"2020","journal-title":"Eur\u00a0J\u00a0Clin\u00a0Invest"},{"issue":"5","key":"10.1016\/j.jacl.2025.12.022_bib19","first-page":"626","article-title":"GPIHBP1 autoantibody is an independent risk factor for the recurrence of hypertriglyceridemia-induced acute pancreatitis","volume":"16","author":"Zhang","year":"2022","journal-title":"J\u00a0Clin\u00a0Lipidol"},{"issue":"5","key":"10.1016\/j.jacl.2025.12.022_bib20","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants (ACMG, 2015)","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"11","key":"10.1016\/j.jacl.2025.12.022_bib21","first-page":"1743","article-title":"Familial chylomicronemia syndrome in children: a diagnosis challenge","volume":"11","author":"Ariza","year":"2022","journal-title":"Transl\u00a0Pediatr"},{"issue":"2","key":"10.1016\/j.jacl.2025.12.022_bib22","first-page":"130","article-title":"Six-year follow-up of a child with familial chylomicronemia syndrome: disease course and effectiveness of gemfibrozil treatment--case report and literature review","volume":"29","author":"Mustafa","year":"2024","journal-title":"Ann\u00a0Pediatr\u00a0Endocrinol\u00a0Metab"},{"issue":"3","key":"10.1016\/j.jacl.2025.12.022_bib23","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0022-3476(98)70280-X","article-title":"Familial lipoprotein lipase deficiency in infancy: clinical, biochemical, and molecular study","volume":"133","author":"Feoli-Fonseca","year":"1998","journal-title":"J Pediatr"},{"issue":"6","key":"10.1016\/j.jacl.2025.12.022_bib24","first-page":"1482","article-title":"Molecular basis of the familial chylomicronemia syndrome in patients from the National Dyslipidemia Registry of the Spanish Atherosclerosis Society","volume":"12","author":"Ariza","year":"2018","journal-title":"J\u00a0Clin\u00a0Lipidol"},{"key":"10.1016\/j.jacl.2025.12.022_bib25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.atherosclerosis.2021.02.020","article-title":"A novel GPIHBP1 mutation related to familial chylomicronemia syndrome: a\u00a0series of cases","volume":"322","author":"Lima","year":"2021","journal-title":"Atherosclerosis"},{"issue":"17","key":"10.1016\/j.jacl.2025.12.022_bib26","first-page":"1647","article-title":"Autoantibodies against GPIHBP1 as a cause of hypertriglyceridemia","volume":"376","author":"Beigneux","year":"2017","journal-title":"N\u00a0Engl\u00a0J\u00a0Med"},{"issue":"11","key":"10.1016\/j.jacl.2025.12.022_bib27","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1194\/jlr.R120001116","article-title":"Chylomicronemia from GPIHBP1 autoantibodies","volume":"61","author":"Miyashita","year":"2020","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jacl.2025.12.022_bib28","article-title":"Pancreatitis as a main consequence of APOC2-related hypertriglyceridemia: the role of nonsense and frameshift variants","volume":"2024","author":"Rabbani","year":"2024","journal-title":"Int\u00a0J\u00a0Genomics"},{"issue":"12","key":"10.1016\/j.jacl.2025.12.022_bib29","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/S0022-2275(20)41340-9","article-title":"Molecular basis of familial chylomicronemia: mutations in the lipoprotein lipase and apolipoprotein C-II genes","volume":"33","author":"Reina","year":"1992","journal-title":"J\u00a0Lipid Res"},{"issue":"3","key":"10.1016\/j.jacl.2025.12.022_bib30","first-page":"551","article-title":"The familial chylomicronemia syndrome","volume":"27","author":"Santamarina-Fojo","year":"1998","journal-title":"Endocrinol\u00a0Metab\u00a0Clin\u00a0North Am"},{"issue":"3","key":"10.1016\/j.jacl.2025.12.022_bib31","first-page":"1","article-title":"New-onset type 1 diabetes in a child with diabetic ketoacidosis and severe hypertriglyceridemia without pancreatitis","volume":"1","author":"Vitale","year":"2023","journal-title":"JCEM Case Rep"},{"issue":"9","key":"10.1016\/j.jacl.2025.12.022_bib32","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.3346\/jkms.2010.25.9.1375","article-title":"Severe hypertriglyceridemia in diabetic ketoacidosis accompanied by acute pancreatitis: case report","volume":"25","author":"Hahn","year":"2010","journal-title":"J\u00a0Korean Med\u00a0Sci"},{"issue":"12","key":"10.1016\/j.jacl.2025.12.022_bib33","first-page":"2531","article-title":"Spectrum of mutations and long-term clinical outcomes in genetic chylomicronemia syndromes","volume":"39","author":"D\u2019Erasmo","year":"2019","journal-title":"Arterioscler\u00a0Thromb\u00a0Vasc\u00a0Biol"},{"issue":"12","key":"10.1016\/j.jacl.2025.12.022_bib34","article-title":"The incidence of propofol-induced hypertriglyceridemia and identification of associated risk factors","volume":"2","author":"Corrado","year":"2020","journal-title":"Crit\u00a0Care Explor"},{"issue":"6","key":"10.1016\/j.jacl.2025.12.022_bib35","first-page":"1172","article-title":"A single bolus of a low molecular weight heparin to patients on haemodialysis depletes lipoprotein lipase stores and retards triglyceride clearing","volume":"20","author":"N\u00e4sstr\u00f6m","year":"2005","journal-title":"Nephrol\u00a0Dial\u00a0Transplant"},{"issue":"1","key":"10.1016\/j.jacl.2025.12.022_bib36","first-page":"1","article-title":"Symptoms and impacts of familial chylomicronemia syndrome: a qualitative study of the patient experience","volume":"18","author":"Williams","year":"2023","journal-title":"Orphanet J\u00a0Rare Dis"},{"issue":"16","key":"10.1016\/j.jacl.2025.12.022_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/nu15163535","article-title":"Long-term treatment of lipoprotein lipase deficiency with medium-chain triglyceride-enriched diet: a case series","volume":"15","author":"Aljouda","year":"2023","journal-title":"Nutrients"},{"issue":"7","key":"10.1016\/j.jacl.2025.12.022_bib38","first-page":"1400","article-title":"Therapeutic response to medium-chain triglycerides and \u03c9-3 fatty acids in a patient with the familial chylomicronemia syndrome","volume":"17","author":"Rouis","year":"1997","journal-title":"Arterioscler\u00a0Thromb\u00a0Vasc\u00a0Biol"},{"issue":"1","key":"10.1016\/j.jacl.2025.12.022_bib39","article-title":"Breaking the chains of lipoprotein lipase deficiency: a pediatric perspective on the efficacy and safety of Volanesorsen","volume":"142","author":"den Hollander","year":"2024","journal-title":"Mol\u00a0Genet\u00a0Metab"},{"issue":"19","key":"10.1016\/j.jacl.2025.12.022_bib40","first-page":"1781","article-title":"Olezarsen, acute pancreatitis, and familial chylomicronemia syndrome","volume":"390","author":"Stroes","year":"2024","journal-title":"N\u00a0Engl\u00a0J\u00a0Med"},{"issue":"2","key":"10.1016\/j.jacl.2025.12.022_bib41","first-page":"127","article-title":"Plozasiran for managing persistent chylomicronemia and pancreatitis risk","volume":"392","author":"Watts","year":"2024","journal-title":"N\u00a0Engl\u00a0J\u00a0Med"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287425005616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287425005616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:05:21Z","timestamp":1777622721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287425005616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1933287425005616"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2025.12.022","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heterogeneous nature of severe hypertriglyceridemia in childhood","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2025.12.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 National Lipid Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}